CervoMed Inc. Files 8-K
Ticker: CRVO · Form: 8-K · Filed: Jul 28, 2025 · CIK: 1053691
| Field | Detail |
|---|---|
| Company | Cervomed Inc. (CRVO) |
| Form Type | 8-K |
| Filed Date | Jul 28, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 8-K, corporate-filing, financials
Related Tickers: CRVO
TL;DR
CervoMed Inc. (CRVO) filed an 8-K on 7/28/25. Nothing major disclosed yet.
AI Summary
CervoMed Inc. filed an 8-K on July 28, 2025, reporting on other events and financial statements. The company, formerly known as Diffusion Pharmaceuticals Inc., RestorGenex Corp, and Stratus Media Group, Inc., is incorporated in Delaware and headquartered in Boston, MA.
Why It Matters
This filing provides an update on CervoMed Inc.'s corporate activities and financial reporting, which is crucial for investors to stay informed about the company's status.
Risk Assessment
Risk Level: low — The filing is a routine 8-K for other events and financial statements, with no immediate material news disclosed.
Key Numbers
- 001-37942 — Commission File Number (Identifies the company's SEC filing history)
- 30-0645032 — I.R.S. Employer Identification No. (Company's tax identification number)
Key Players & Entities
- CervoMed Inc. (company) — Registrant
- Diffusion Pharmaceuticals Inc. (company) — Former Company Name
- RestorGenex Corp (company) — Former Company Name
- Stratus Media Group, Inc (company) — Former Company Name
- July 28, 2025 (date) — Date of Report
FAQ
What specific 'Other Events' are being reported by CervoMed Inc. in this 8-K?
The filing indicates 'Other Events' as an item information, but the specific details of these events are not provided in the excerpt.
What is the significance of the 'Financial Statements and Exhibits' being filed?
This indicates that the company is providing updated financial information and supporting documents as required by the SEC.
When did CervoMed Inc. change its name from Diffusion Pharmaceuticals Inc.?
The filing states the date of name change from Diffusion Pharmaceuticals Inc. was 20160115.
What is CervoMed Inc.'s principal executive office address?
The principal executive offices are located at 20 Park Plaza, Suite 424, Boston, Massachusetts 02116.
What is CervoMed Inc.'s Standard Industrial Classification code?
CervoMed Inc.'s Standard Industrial Classification code is 2834, which corresponds to Pharmaceutical Preparations.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 28, 2025 regarding CervoMed Inc. (CRVO).